19-44328641-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013380.4(ZNF112):c.1516C>T(p.Leu506Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013380.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF112 | NM_013380.4 | c.1516C>T | p.Leu506Phe | missense_variant | 4/4 | ENST00000354340.9 | NP_037512.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF112 | ENST00000354340.9 | c.1516C>T | p.Leu506Phe | missense_variant | 4/4 | 1 | NM_013380.4 | ENSP00000346305.3 | ||
ZNF112 | ENST00000337401.8 | c.1534C>T | p.Leu512Phe | missense_variant | 5/5 | 1 | ENSP00000337081.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250902Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135574
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461806Hom.: 0 Cov.: 81 AF XY: 0.0000151 AC XY: 11AN XY: 727204
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.1534C>T (p.L512F) alteration is located in exon 5 (coding exon 4) of the ZNF112 gene. This alteration results from a C to T substitution at nucleotide position 1534, causing the leucine (L) at amino acid position 512 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at